Efficacy of epidural dexamethasone versus fentanyl on postoperative analgesia.
OBJECTIVE
Dexamethasone has analgesic, anti-inflammatory, and antiemetic effects. This prospective, randomized, double-blind, controlled study was designed to evaluate the efficacy of adding dexamethasone versus fentanyl to epidural bupivacaine on postoperative analgesia.


METHODS
Ninety patients ASA I-II scheduled for lower abdominal surgeries were randomly allocated into three groups to receive a total of 10 mL epidural plain bupivacaine 0.25% in the control group (group B), with either 50 microg fentanyl in group BF or 4 mg dexamethasone in group BD. Patients then received general anesthesia. Sedation, satisfaction, and visual analogue pain scores (VAS) were measured postoperatively. Meperidine was administered when VAS > or =4. Intraoperative fentanyl dose, postoperative meperidine consumption, and the time to first analgesic requirement were recorded.


RESULTS
Intraoperative fentanyl requirements were comparable among groups. Time to first analgesic requirement was significantly prolonged (5.2 times) in the BF group and (4.8 times) in the BD group compared with group B (p < 0.01). There was significant reduction in postoperative meperidine consumption during the first 24 h in the BF and BD groups (65, 62.5% respectively) in comparison with group B (p < 0.01). VAS scores were significantly lower and patient satisfaction score was significantly higher in the BF and BD groups compared with group B (p < 0.01). Postoperative nausea was significantly lower in the BD group versus the B and BF groups (p < 0.05).


CONCLUSIONS
This study revealed that epidural bupivacaine-dexamethasone admixture had almost the same analgesic potency as bupivacaine-fentanyl with opioid-sparing and antiemetic effects. Further studies are required to evaluate the optimum dose of epidural dexamethasone for postoperative analgesia.
Khafagy
Hanan F
HF
Department of Anesthesiology, Theodor Bilharz Research Institute, Ministry of High Education and Scientific Research, Warak El-Hadar, Kornish El-Nile, P.O. Box 30 Imbaba, Giza, 12411, Egypt. hananfkhafagy993@hotmail.com
Refaat
Ahmed I
AI
El-Sabae
Hossam H
HH
Youssif
Maha A
MA
D000328:Adult; D000368:Aged; D015360:Analgesia, Epidural; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D002045:Bupivacaine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010149:Postoperative Pain / Q000188:drug therapy*; D011446:Prospective Studies
D000701:Analgesics, Opioid; D003907:Dexamethasone; D005283:Fentanyl; D002045:Bupivacaine
Endocr Rev. 2000 Feb;21(1):55-89
10696570
Anesth Analg. 1998 Aug;87(2):319-23
9706923
Spine (Phila Pa 1976). 2006 Oct 1;31(21):2415-7
17023848
J Biol Chem. 1999 Jun 11;274(24):17202-8
10358078
J Allergy Clin Immunol. 1988 Oct;82(4):696-700
3171010
Can J Anaesth. 1997 Apr;44(4):377-84
9104519
Br J Anaesth. 1991 Jan;66(1):31-7
1997056
Anesth Analg. 1999 Aug;89(2):476-9
10439770
Anesth Analg. 2003 Jul;97(1):62-71, table of contents
12818945
Neuroscience. 1999;93(2):775-81
10465460
Br J Anaesth. 2001 Oct;87(4):635-8
11878738
Anesth Analg. 2000 Jan;90(1):186-94
10625002
Ann Surg. 1993 Oct;218(4):419-25; discussion 425-7
8215634
Anesth Analg. 1997 Feb;84(2):376-8
9024032
Rev Rhum Engl Ed. 1995 Jun;62(6):429-32
7552207
Neurosurgery. 2000 Jan;46(1):178-82; discussion 182-3
10626948
Drugs. 2003;63(9):855-67
12678572
Br J Cancer. 2006 Apr 10;94(7):1011-5
16552437
N Engl J Med. 1983 Jul 7;309(1):21-4
6343871
Eur J Anaesthesiol. 1998 May;15(3):342-4
9649996
Clin Orthop Relat Res. 1977 Nov-Dec;(129):72-8
75775
Acta Anaesthesiol Scand. 1990 Jul;34(5):335-8
2167604
Anaesthesia. 1993 Nov;48(11):961-4
8250191
Ann Surg. 2003 Nov;238(5):651-60
14578725
Health Technol Assess. 2005 Aug;9(33):1-58, iii
16095548
Can J Anaesth. 2006 Sep;53(9):899-905
16960268
Clin Sci (Lond). 1998 Jun;94(6):557-72
9854452
Anesth Analg. 2009 Aug;109(2):607-15
19608838
Drug Saf. 2000 Nov;23(5):449-61
11085349